1.Primary peritoneal pregnancy implanted on the uterosacral ligament: a case report.
Joong Sik SHIN ; Young Jin MOON ; Seung Ryong KIM ; Kyung Tai KIM ; Hyung MOON ; Youn Yeung HWANG
Journal of Korean Medical Science 2000;15(3):359-362
Peritoneal pregnancies are classified as primary and secondary. Primary implantation on the peritoneum is extremely rare in extrauterine pregnancy and is a potentially life-threatening variation of ectopic pregnancy within the peritoneal cavity, representing a grave risk to maternal health. Secondary abdominal pregnancies are by far the most common and result from tubal abortion or rupture, or less often, after uterine rupture with subsequent implantation within abdomen. Early diagnosis and appropriate surgical management, regardless of stage of gestation, appear to be important in achieving good results. We report a case of primary peritoneal pregnancy in a 28-year-old woman, who had severe lower abdominal pain one day before laparotomy for a preoperative diagnosis of ectopic pregnancy. The conceptus was implanted on the left uterosacral ligament. A fresh embryo of approximately 8 weeks' gestation was found in the conceptus.
Adult
;
Case Report
;
Female
;
Follow-Up Studies
;
Hemoperitoneum/surgery
;
Hemoperitoneum/diagnosis
;
Hemoperitoneum/complications*
;
Human
;
Ligaments
;
Ovum Implantation
;
Peritoneum/pathology
;
Pregnancy
;
Pregnancy, Abdominal/surgery
;
Pregnancy, Abdominal/pathology
;
Pregnancy, Abdominal/diagnosis
;
Pregnancy, Abdominal/complications*
;
Rupture, Spontaneous/surgery
;
Rupture, Spontaneous/diagnosis
;
Sacrum
;
Uterus/pathology
2.Gastric gastrointestinal stromal tumor: Does the newly proposed UICC TNM staging system provide better prognostic ability than the National Institutes of Health consensus criteria?
Hyeongcheol KIM ; Seung Jong OH ; Min Young KOO ; Jenny Jimmy HONG ; Young Taek KOH ; Min Gew CHOI ; Tae Sung SOHN ; Kyoung Mee KIM ; Jae Moon BAE ; Sung KIM
Korean Journal of Clinical Oncology 2016;12(2):83-90
PURPOSE: The main limitation of the National Institutes of Health (NIH) consensus criteria is the biological and prognostic heterogeneity of tumors while the utility of the newly proposed UICC TNM staging system has not yet been validated. Our object is to compare the overall and disease-free survival (DFS) of patients with gastric gastrointestinal stromal tumors (GIST) using the UICC TNM staging system and the NIH consensus criteria and to determine the optimal risk stratification system for GIST.METHODS: Retrospective analysis of 164 patients who underwent operative management for primary gastric GIST between 1994 and 2004.RESULTS: The overall five-year survival rate was 89.6%. In the 149 patients who underwent an R0 resection, the five-year DFS rate was 86.3%. According to the NIH consensus criteria, the five-year survival rate after resection was 100% for patients in the very low-, low-, and intermediate-risk groups and 71.9% for patients in the high-risk group. The UICC TNM stages IA, IB, and II had the same survival rates (100%) and stage IIIA (75.0%) and stage IIIB (69.5%) showed no significant difference in survival compared to the NIH criteria, which precluded better risk stratification. The patients who were included in the high-risk group by NIH consensus criteria (>10 cm, ≤5/50 high power field) and were stage II by the UICC TNM staging system had a 100% five-year survival rate.CONCLUSION: Using the current schemes, one system does not demonstrate superior prognostic ability over the other. However, the high-risk group (T4/low mitotic rate) and stage II patients appear to be appropriately classified.
Classification
;
Consensus
;
Disease-Free Survival
;
Gastrointestinal Stromal Tumors
;
Humans
;
National Institutes of Health (U.S.)
;
Neoplasm Staging
;
Population Characteristics
;
Retrospective Studies
;
Survival Rate
3.Incidence and case fatality of stroke in Korea, 2011-2020
Jenny MOON ; Yeeun SEO ; Hyeok-Hee LEE ; Hokyou LEE ; Fumie KANEKO ; Sojung SHIN ; Eunji KIM ; Kyu Sun YUM ; Young Dae KIM ; Jang-Hyun BAEK ; Hyeon Chang KIM
Epidemiology and Health 2024;46(1):e2024003-
OBJECTIVES:
Stroke remains the second leading cause of death in Korea. This study was designed to estimate the crude, age-adjusted and age-specific incidence rates, as well as the case fatality rate of stroke, in Korea from 2011 to 2020.
METHODS:
We utilized data from the National Health Insurance Services from January 1, 2002 to December 31, 2020, to calculate incidence rates and 30-day and 1-year case fatality rates of stroke. Additionally, we determined sex and age-specific incidence rates and computed age-standardized incidence rates by direct standardization to the 2005 population.
RESULTS:
The crude incidence rate of stroke hovered around 200 (per 100,000 person-years) from 2011 to 2015, then surged to 218.4 in 2019, before marginally declining to 208.0 in 2020. Conversely, the age-standardized incidence rate consistently decreased by 25% between 2011 and 2020. When stratified by sex, the crude incidence rate increased between 2011 and 2019 for both sexes, followed by a decrease in 2020. Age-standardized incidence rates displayed a downward trend throughout the study period for both sexes. Across all age groups, the 30-day and 1-year case fatality rates of stroke consistently decreased from 2011 to 2019, only to increase in 2020.
CONCLUSIONS
Despite a decrease in the age-standardized incidence rate, the total number of stroke events in Korea continues to rise due to the rapidly aging population. Moreover, 2020 witnessed a decrease in incidence but an increase in case fatality rates.
4.Incidence and case fatality of acute myocardial infarction in Korea, 2011-2020
Yeeun SEO ; Jenny MOON ; Hyeok-Hee LEE ; Hyeon Chang KIM ; Fumie KANEKO ; Sojung SHIN ; Eunji KIM ; Jang-Whan BAE ; Byeong-Keuk KIM ; Seung Jun LEE ; Min KIM ; Hokyou LEE
Epidemiology and Health 2024;46(1):e2024002-
OBJECTIVES:
Cardiovascular diseases are a leading cause of mortality worldwide, and acute myocardial infarction (AMI) is particularly fatal condition. We evaluated the incidence and case fatality rates of AMI in Korea from 2011 to 2020.
METHODS:
We utilized data from the National Health Insurance Services to calculate crude, age-standardized, and age-specific incidence rates, along with 30-day and 1-year case fatality rates, of AMI from 2011 to 2020. Age-standardized incidence rates were determined using direct standardization to the 2005 population.
RESULTS:
The crude incidence rate of AMI per 100,000 person-years consistently increased from 44.7 in 2011 to 68.3 in 2019, before decreasing slightly to 66.2 in 2020. The age-standardized incidence rate of AMI displayed a 19% rise from 2011 to 2019, followed by a slight decline in 2020. The increasing trend for AMI incidence was more pronounced in males than in females. Both 30-day and 1-year case fatality rates remained stable among younger individuals but showed a decrease among older individuals. There was a minor surge in case fatality in 2020, particularly among recurrent AMI cases.
CONCLUSIONS
Over the past decade, the AMI incidence rate in Korea has consistently increased, with a slight downturn in 2020. The case fatality rate has remained relatively stable except for a minor increase in 2020. This study provides data for continuous surveillance, the implementation of targeted interventions, and the advancement of research aimed at AMI in Korea.
5.Dyslipidemia Fact Sheet in South Korea, 2022
Eun-Sun JIN ; Jee-Seon SHIM ; Sung Eun KIM ; Jae Hyun BAE ; Shinae KANG ; Jong Chul WON ; Min-Jeong SHIN ; Heung Yong JIN ; Jenny MOON ; Hokyou LEE ; Hyeon Chang KIM ; In-Kyung JEONG ;
Diabetes & Metabolism Journal 2023;47(5):632-642
Background:
This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name Dyslipidemia Fact Sheet 2022.
Methods:
We analyzed the lipid profiles, age-standardized and crude prevalence, management status of hypercholesterolemia and dyslipidemia, and health behaviors among Korean adults aged ≥20 years, using the Korea National Health and Nutrition Examination Survey data between 2007 and 2020.
Results:
In South Korea, the crude prevalence of hypercholesterolemia (total cholesterol ≥240 mg/dL or use of a lipid-lowering drug) in 2020 was 24%, and the age-standardized prevalence of hypercholesterolemia more than doubled from 2007 to 2020. The crude treatment rate was 55.2%, and the control rate was 47.7%. The crude prevalence of dyslipidemia—more than one out of three conditions (low-density lipoprotein cholesterol ≥160 or the use of a lipid-lowering drug, triglycerides ≥200, or high-density lipoprotein cholesterol [HDL-C] [men and women] <40 mg/dL)—was 40.2% between 2016 and 2020. However, it increased to 48.2% when the definition of hypo-HDL-cholesterolemia in women changed from <40 to <50 mg/dL.
Conclusion
Although the prevalence of hypercholesterolemia and dyslipidemia has steadily increased in South Korea, the treatment rate remains low. Therefore, continuous efforts are needed to manage dyslipidemia through cooperation between the national healthcare system, patients, and healthcare providers.
6.Dyslipidemia Fact Sheet in South Korea, 2022
Eun-Sun JIN ; Jee-Seon SHIM ; Sung Eun KIM ; Jae Hyun BAE ; Shinae KANG ; Jong Chul WON ; Min-Jeong SHIN ; Heung Yong JIN ; Jenny MOON ; Hokyou LEE ; Hyeon Chang KIM ; In-Kyung JEONG ;
Journal of Lipid and Atherosclerosis 2023;12(3):237-251
Objective:
This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name Dyslipidemia Fact Sheet 2022.
Methods:
We analyzed the lipid profiles, age-standardized and crude prevalence, management status of hypercholesterolemia and dyslipidemia, and health behaviors among Korean adults aged ≥20 years, using the Korea National Health and Nutrition Examination Survey data between 2007 and 2020.
Results:
In South Korea, the crude prevalence of hypercholesterolemia (total cholesterol ≥240 mg/dL or use of a lipid-lowering drug) in 2020 was 24%, and the age-standardized prevalence of hypercholesterolemia more than doubled from 2007 to 2020. The crude treatment rate was 55.2%, and the control rate was 47.7%. The crude prevalence of dyslipidemia (more than one out of three conditions [low-density lipoprotein-cholesterol ≥160 or the use of a lipid-lowering drug, triglycerides ≥200, or high-density lipoprotein-cholesterol (men and women) <40 mg/ dL]) was 40.2% between 2016 and 2020. However, it increased to 48.2% when the definition of hypo-high-density lipoprotein-cholesterolemia in women changed from <40 to <50 mg/dL.
Conclusion
Although the prevalence of hypercholesterolemia and dyslipidemia has steadily increased in South Korea, the treatment rate remains low. Therefore, continuous efforts are needed to manage dyslipidemia through cooperation between the national healthcare system, patients, and healthcare providers.